Funder: National Institutes of Health
Due Dates: May 25, 2025 (New, Renewal, Resubmission, Revision) | September 25, 2025 (New, Renewal, Resubmission, Revision) | Letters of Intent: April 25, 2025 & August 25, 2025 (30 days prior to application due date)
Funding Amounts: Up to $1,400,000 direct costs/year (plus up to $120,000/year for qualified EPPS or CHD-MH projects); maximum project period 5 years.
Summary: Supports multi-project, investigator-initiated translational research centers focused on prevention, detection, diagnosis, and treatment of organ-specific or related human cancers, requiring at least one clinical trial per application.
Key Information: Limited submission: an investigator may serve as PI/multi-PI on only one funded SPORE P50 at a time; clinical trial(s) are required.